A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy

被引：0
|
作者：
Mark E Hwang
Paul J Black
Carl D Elliston
Brian A Wolthuis
Deborah R Smith
Cheng-Chia Wu
Sven Wenske
Israel Deutsch
机构：
[1] Columbia University Medical Center,Department of Radiation Oncology
[2] Columbia University Medical Center,Department of Urology
来源：
Radiation Oncology | / 13卷
关键词：
Prostate cancer; Stereotactic body radiotherapy; Rectal toxicity; SpaceOAR hydrogel; Dosimetry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 30 条
  • [21] Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison
    Mami Ogita
    Hideomi Yamashita
    Yuki Nozawa
    Sho Ozaki
    Subaru Sawayanagi
    Takeshi Ohta
    Keiichi Nakagawa
    Radiation Oncology, 16
  • [22] Who will benefit most from hydrogel rectum spacer implantation in prostate cancer radiotherapy? A model-based approach for patient selection
    Vanneste, Ben G. L.
    Hoffmann, Aswin L.
    van Lin, Emile N.
    Van de Voorde, Lien
    Pinkawa, Michael
    Lambin, Philippe
    RADIOTHERAPY AND ONCOLOGY, 2016, 121 (01) : 118 - 123
  • [23] Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function
    Hwang, Mark E.
    Mayeda, Mark
    Shaish, Hiram
    Elliston, Carl D.
    Spina, Catherine S.
    Wenske, Sven
    Deutsch, Israel
    BRITISH JOURNAL OF RADIOLOGY, 2021, 94 (1119):
  • [24] Stereotactic body radiotherapy using a hydrogel spacer for localized prostate cancer: A dosimetric comparison between tomotherapy with the newly-developed tumor-tracking system and cyberknife
    Manabe, Yoshihiko
    Hashimoto, Seiji
    Mukouyama, Hideki
    Shibamoto, Yuta
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2021, 22 (10): : 66 - 72
  • [25] Stereotactic Body Radiotherapy Using a Hydrogel Spacer for Localized Prostate Cancer: A Dosimetric Study Between Tomotherapy With the Newly-Developed Tumor-Tracking System and CyberKnife
    Manabe, Y.
    Hashimoto, S.
    Mukouyama, H.
    Shibamoto, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E277 - E277
  • [26] Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy
    Cuccia, Francesco
    Mazzola, Rosario
    Nicosia, Luca
    Figlia, Vanessa
    Giaj-Levra, Niccolo
    Ricchetti, Francesco
    Rigo, Michele
    Vitale, Claudio
    Mantoan, Beatrice
    De Simone, Antonio
    Sicignano, Gianluisa
    Ruggieri, Ruggero
    Cavalleri, Stefano
    Alongi, Filippo
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [27] Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer
    Mazzola, Rosario
    Sicignano, Gianluisa
    Cuccia, Francesco
    Vitale, Claudio
    Rigo, Michele
    Giaj-Levra, Niccolo
    Nicosia, Luca
    Figlia, Vanessa
    Ricchetti, Francesco
    Attina, Giorgio
    Pastorello, Edoardo
    De Simone, Antonio
    Gurrera, Davide
    Naccarato, Stefania
    Ruggieri, Ruggero
    Alongi, Filippo
    BRITISH JOURNAL OF RADIOLOGY, 2021, 94 (1126):
  • [28] In regard to Cuccia et al.: impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy
    Hamed Ghaffari
    Mahmoud Navaser
    Soheila Refahi
    Radiation Oncology, 15
  • [29] In regard to Cuccia et al.: impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy
    Ghaffari, Hamed
    Navaser, Mahmoud
    Refahi, Soheila
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [30] Reply to Ghaffari et al. “In regard to Cuccia et al.: impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.”
    Francesco Cuccia
    Filippo Alongi
    Radiation Oncology, 15
123